Exposing human GEnC to diabetic conditions resulted in MMP upregulation and GEnGlx damage that were both ameliorated by MR antagonism.
Secreted gelatinases MMP2 and MMP9 can be activated by cell membrane–bound membrane type 1 MMP, also known as MMP14 (